Talking Urology Podcast

Michael Hofman discusses the new ANZUP/PCFA trial investigating therapeutic Lutetium (Lu-177) PSMA for men with advanced mCRPC.

Bente Thoft Jensen discusses the advancements in prehabiliatation prior to radical cystectomy.

Dennis Taaffe discusses the RADAR trial investigating the important benefits of exercise in men with prostate cancer

David Quinn discusses the KEYNOTE-045 trial on the benefits of pembrolizumab in second line treatment of advanced bladder cancer

Peter Black discusses the dizzying array of new treamtment options on the horizon for advanced bladder cancer

Renea Taylor discusses her research on the poor prognosis associated with BRCA 2 mutation prostate cancer

Alex Kutikov discusses predictors of pT0 bladder cancer after neoadjuvant chemotherapy; can we avoid cystectomy in these patients?

Matthew Roberts discusses the role of seminal plasma (ejaculate) for monitoring men on active surveillance for prostate cancer

Ada Cheung discusses the often missed diagnosis of hypogonadism in men who have had treatment for testicular cancer.

Bill Catalona gave the annual Patrick C Walsh lecture and discusses the 3 big wins in improving prostate cancer outcomes in the PSA era.